Using patient-derived material, we observed that strong SRSF2 over-expression in NSCLC is associated with splicing alterations of the HER1/EGFR and VEGFA transcripts, as predicted from the results in the SRSF2-over-expressing H358 lung cancer cell line. This evidence concerns the gene SRSF2 and lung carcinoma.